Literature DB >> 28543560

Borderline personality disorder, mentalization, and the neurobiology of attachment.

Peter Fonagy1, Patrick Luyten2, Lane Strathearn3.   

Abstract

We discuss the neural and neurobiological underpinnings of the core features of borderline personality disorder (BPD), including emotion dysregulation, impulsivity, disturbed interpersonal functioning, identity diffusion, and feelings of inner pain. We review neurobiological research that supports a developmental, biobehavioral switch-model of the relationship between mentalization, stress, and attachment. Although it is likely that there are different developmental pathways to BPD, involving complex interactions between environmental, biological, and psychosocial factors, the final common outcome of these pathways is a low threshold for the activation of the attachment system and for deactivation of controlled mentalization, coupled with impairments in the ability to differentiate mental states of self and other. This leads to hypersensitivity and increased susceptibility to contagion from other people's mental states, poor integration of cognitive and affective aspects of mentalization, and dysfunctions in stress-regulation systems. The treatment implications of this neurobiologically informed model of BPD are discussed.
Copyright © 2011 Michigan Association for Infant Mental Health.

Entities:  

Year:  2011        PMID: 28543560     DOI: 10.1002/imhj.20283

Source DB:  PubMed          Journal:  Infant Ment Health J        ISSN: 0163-9641


  11 in total

Review 1.  Recent advances in the developmental aspects of borderline personality disorder.

Authors:  Carla Sharp; Sohye Kim
Journal:  Curr Psychiatry Rep       Date:  2015-04       Impact factor: 5.285

2.  Social disadvantage and borderline personality disorder: A study of social networks.

Authors:  Joseph E Beeney; Michael N Hallquist; Allan D Clifton; Sophie A Lazarus; Paul A Pilkonis
Journal:  Personal Disord       Date:  2016-12-12

3.  Exploring maternal reflective functioning as a predictor of mother-child dyadic behaviour over time in a clinical context.

Authors:  Lindsey Myers; Howard Steele; Miriam Steele; Anne Murphy
Journal:  Res Psychother       Date:  2022-04-27

Review 4.  Biting the hand that feeds: current opinion on the interpersonal causes, correlates, and consequences of borderline personality disorder.

Authors:  Sheila E Crowell
Journal:  F1000Res       Date:  2016-11-30

5.  A Diagnosis of Denial: How Mental Health Classification Systems Have Struggled to Recognise Family Violence as a Serious Risk Factor in the Development of Mental Health Issues for Infants, Children, Adolescents and Adults.

Authors:  Wendy Bunston; Candice Franich-Ray; Sara Tatlow
Journal:  Brain Sci       Date:  2017-10-17

6.  The parental reflective functioning questionnaire: Development and preliminary validation.

Authors:  Patrick Luyten; Linda C Mayes; Liesbet Nijssens; Peter Fonagy
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

7.  Childhood Trauma, Personality, and Substance Use Disorder: The Development of a Neuropsychoanalytic Addiction Model.

Authors:  Jürgen Fuchshuber; Human Friedrich Unterrainer
Journal:  Front Psychiatry       Date:  2020-06-09       Impact factor: 4.157

8.  Brain mechanisms underlying the impact of attachment-related stress on social cognition.

Authors:  Tobias Nolte; Danielle Z Bolling; Caitlin M Hudac; Peter Fonagy; Linda Mayes; Kevin A Pelphrey
Journal:  Front Hum Neurosci       Date:  2013-11-27       Impact factor: 3.169

9.  Examining changes in personality disorder and symptomology in an adolescent sample receiving intensive mentalization based treatment: a pilot study.

Authors:  Kirsten Hauber; Albert Eduard Boon; Robert Vermeiren
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2017-11-28       Impact factor: 3.033

10.  Social judgement in borderline personality disorder.

Authors:  Katie Nicol; Merrick Pope; Reiner Sprengelmeyer; Andrew W Young; Jeremy Hall
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.